Articles From: Staples Survey Shows Purchasing Departments Need to Keep Pace with Rise in Telecommuting to Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes


2014/11/12
The overwhelming majority of employees believe telecommuting is good for both themselves and their company, but most organizations are not budgeting appropriately for telecommuters, according to a recent survey of procurement officers by Staples Advantage , the business-to-business division of Staples, Inc. Two-thirds of those who responded say they do not take telecommuters into account when planning their organization’s purchasing budget.
Sign-up for Staples Survey Shows Purchasing Departments Need to Keep Pace with Rise in Telecommuting investment picks
2014/11/12
- Net income up 19.1% excluding impact of legal settlement - Net sales for the quarter increased by 1.9% - Board declares quarterly cash dividend of $0.08 per share Olivia W.
Sign-up for Crown Crafts Reports Results for Second Quarter of Fiscal 2015 investment picks
LEXINGTON, Mass., Nov.
Sign-up for Curis to Present at the Stifel 2014 Healthcare Conference investment picks
Company to Host Conference Call Today, November 12, 2014, at 11:00 AM ET ST.
Sign-up for EnteroMedics Reports Third Quarter 2014 Financial Results investment picks
2014/11/12
GOLDEN, Colo.
Sign-up for Atna Reports Third Quarter 2014 Earnings and Operations Results investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) , a clinical-stage biopharmaceutical company whose lead product candidate, eravacycline, is being developed as a broad-spectrum intravenous and oral antibiotic designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) Gram-negative pathogens), today announced its participation in two upcoming investor conferences: A live audio webcast of the Stifel presentation will be available on the Company's website at http://ir.tphase.com/events.cfm .
Sign-up for Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences investment picks
Starwood Waypoint Residential Trust (NYSE:SWAY) (the “Company”), a leading single-family rental real estate investment trust (“REIT”), today announced its operating and financial results for the third quarter 2014.
Sign-up for Starwood Waypoint Residential Trust Announces Third Quarter 2014 Financial and Operating Results investment picks
bluebird bio, Inc. (Nasdaq:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today reported financial results and operational highlights for the quarter ended September 30, 2014.
Sign-up for bluebird bio Reports Fiscal Third Quarter 2014 Financial Results investment picks
The Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, a pilot initiative, will provide pro-bono oral care for 250-300 Holocaust survivors across nine North American cities MELVILLE, N.Y. , Nov.
Sign-up for Henry Schein and Alpha Omega International Dental Fraternity Answer the White House's Call to Action to Enhance the Quality of Life of Holocaust Survivors investment picks
2014/11/12
FREMONT, Calif.
Sign-up for Men's Wearhouse Announces In-Home Wedding Apparel Service investment picks
Moody’s Corporation (NYSE:MCO) today announced that Raymond W.
Sign-up for Moody's Corporation Announces Change to Presentation Time at the Wells Fargo TMT Conference on November 13, 2014 in New York investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2014 and provided an update on its pipeline and CTP-354.
Sign-up for Concert Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Update on CTP-354 Program investment picks
Aradigm Corporation (Nasdaq:ARDM) (the “Company”) today announced that Igor Gonda, Aradigm’s President and Chief Executive Officer, will present an overview of the Company at the Stifel Healthcare Conference 2014 at the New York Palace Hotel in New York, New York on Tuesday, November 18, 2014 at 8:00 am Eastern time.
Sign-up for Aradigm to Present at the Stifel Healthcare Conference 2014 investment picks
Next-Generation MCUs for IoT, Sensor Fusion, Industrial Automation, Motor Control and Wireless Connectivity Applications Will Incorporate New Core SUNNYVALE, Calif.
Sign-up for Spansion Licenses ARM's High-Performance Cortex-M7 Processor investment picks
Kamada Ltd.
Sign-up for Kamada Announces Third Quarter 2014 Financial Results investment picks
Markit Ltd.
Sign-up for Markit Reports Third Quarter 2014 Financial Results investment picks
BRIDGEVILLE, Pa., Nov.
Sign-up for Universal Stainless to Present at Midwest Investment Conference on November 18th investment picks
MIDDLETOWN, R.I., Nov.
Sign-up for Photo Release -- KVH Offering Videotel's New Ebola Safety Video Free to Mariners investment picks
Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE:IBP), an industry-leading installer of insulation and complementary building products, announced today results for the third quarter ended September 30, 2014.
Sign-up for Installed Building Products Reports Results for Third Quarter 2014 investment picks
NAIROBI, Kenya , Nov.
Sign-up for Kenya Power Taps IBM Real Time Data Solutions To Improve Business Performance investment picks
DALLAS , Nov.
Sign-up for Alon USA Partners To Acquire Krotz Springs Refinery From Alon Energy investment picks
Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that Ron Cohen, M.D., President and Chief Executive Officer will present at the Stifel 2014 Healthcare Conference on Tuesday, November 18 at 1:50pm ET.
Sign-up for Acorda Therapeutics to Present at the Stifel 2014 Healthcare Conference investment picks
Ocular Therapeutix (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the third quarter ended September 30, 2014, and provided an update on current business developments.
Sign-up for Ocular Therapeutix™ Reports Third Quarter 2014 Financial Results investment picks
2014/11/12
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Jefferies 2014 Global London Healthcare Conference in London.
Sign-up for Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare Conference on November 19th investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Staples Survey Shows Purchasing Departments Need to Keep Pace with Rise in Telecommuting to Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent